U.S. Preventive Services Task Force A and B recommendations
U.S. Preventive Services Task Force
A systematic evidence review examined evidence from new randomized clinical trials and cohort studies published from 2014 to August 2019.
The systematic review concludes with moderate certainty that screening for HBV infection in adolescents and adults at increased risk for infection has moderate net benefit. This recommendation statement applies to asymptomatic, nonpregnant adolescents and adults at increased risk for HBV infection, including those who were vaccinated before being screened ...
U.S. Preventive Services Task Force A and B recommendations
U.S. Preventive Services Task Force
"Prevalence of hypertension (both primary and secondary) in children and adolescents in the US ranges from 3%to 4%. The USPSTF commissioned a systematic evidence review to update its 2013 recommendation on screening for high blood pressure in children and adolescents.1,13 The USPSTF reviewed the evidence on the benefits of screening, test accuracy, the effectiveness and harms of treatment, and the association between hypertension and markers of cardiovascular disease in childhood and adulthood. ...
U.S. Preventive Services Task Force A and B recommendations
U.S. Preventive Services Task Force
Approximately 20 million new cases of bacterial or viral sexually transmitted infections (STIs) occur each year in the US, and about one-half of these cases occur in persons aged 15 to 24 years. Rates of chlamydial, gonococcal, and syphilis infection continue to increase in all regions. Sexually transmitted infections are frequently asymptomatic, which may delay diagnosis and treatment and lead persons to unknowingly transmit STIs to others. Serious consequences of STIs include pelvic ...
U.S. Preventive Services Task Force A and B recommendations
U.S. Preventive Services Task Force
An estimated 12% of adults 18 years or older and 8% of adolescents aged 12 to 17 years report unhealthy use of prescription or illegal drugs in the US. The USPSTF recommends screening for drug abuse in adults 18 years of age and older by questioning only when appropriate diagnosis, care, and treatment can be offered. In the adolescent population, the USPSTF concludes that the current evidence is insufficient to evaluate the balance of benefits and harms of screening for the use of harmful ...
U.S. Preventive Services Task Force A and B recommendations
U.S. Preventive Services Task Force
Tobacco use is the leading cause of preventable death in the US. An estimated annual 480 000 deaths are attributable to tobacco use in adults, including from secondhand smoke. It is estimated that every day about 1600 youth aged 12 to 17 years smoke their first cigarette and that about 5.6 million adolescents alive today will die prematurely from a smoking-related illness. Exposure to nicotine during adolescence can harm the developing brain, which may affect brain function and cognition, ...